Restoration of bacterial killing activity of human respiratory cystic fibrosis cells through cationic vector-mediated cystic fibrosis transmembrane conductance regulator gene transfer

Human Gene Therapy

Volumn 10, Issue 12, 1999, Pages 1923-1930

  Biffi, Alessandra ^a   Sersale, Giovanna ^b   Cassetti, Arianna ^b,c   Villa, Antonello ^b,c   Bordignon, Claudio ^a   Assael, Baroukh M ^b   Conese, Massimo ^a  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; LIPOSOME; LUCIFERASE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BIOASSAY; CELL ACTIVITY; EXPRESSION VECTOR; GENE TRANSFER; HUMAN; HUMAN CELL; LUNG INFECTION; NOSE POLYP; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REGULATOR GENE;

CATIONS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA, COMPLEMENTARY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; NASAL POLYPS; ORGAN CULTURE TECHNIQUES; PHOSPHATIDYLETHANOLAMINES; PLASMIDS; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

BACTERIA (MICROORGANISMS); PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0033543073     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017284     Document Type: Article

References (36)

1. ALTON, E.W.F.W., STERN, M., FARLEY, R. JAFFE, A., CHADWICK, S.L., PHILIPS, J., DAVIES, J., SMITH, S.N., BROWNING, J., DAVIES, M.G., HUDSON, M.E., DURHAM, S.R., LI, D., JEFFERY, P.K., SCALLAN, M., BAFOUR, R., EADTMAN, S.J., CHENG, S.H., SMITH, A.E., MEEKER, D., and GEDDES, D.M. (1999). Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: A double-blind placebo-controlled trial. Lancet 353, 947-954.
2. ARMSTRONG, D.S., GRIMWOOD, K., CARZINO, R., CARLIN, J.B., OLINSKI, A., and PHELAN, P.D. (1995). Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. Br. Med. J. 310, 1571-1572.
3. ARMSTRONG, D.S., GRIMWOOD, K., CARLIN, J.B., CARZINO, R., GUTTIERREZ, J.P., HULL, J., OLINSKY, A., PHELAN, E.M., ROBERTSON, C.F., and PHELAN, P.D. (1997). Lower airway inflammation in infants and young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 156, 1197-1204.
4. BARASCH, J., KISS, B., PRINCE, A., SAIMAN, L., GRUENERT, D., and AL-AWQATI, Q. (1991). Defective acidification of intracellular organelles in cystic fibrosis. Nature (London) 352, 70-73.
5. BEHR, J.-P., DEMENEIX, B., LOEFFLER, J.-P., and MUTUL, J.-P. (1989). Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc. Natl. Acad. Sci. U.S.A. 86, 6982-6986.
6. BIFFI, A., BRAGONZI, A., SERSALE, G., BORDIGNON, C., ASSAEL, B.M., and CONESE, M. (1998). Molecular and cellular barriers to cationic vector-mediated gene delivery to CF respiratory cells. Pediatr. Pulmonol. 17(Suppl.), 264-265.
7. BOLETTA, A., BENIGNI, A., LUTZ, J., REMUZZI, G., SORIA, M.R., and MONACO, L. (1997). Nonviral gene delivery to the rat kidney with polyethylenimine. Hum. Gene Ther. 8, 1243-1251.
8. BOUSSIF, O., LEZOULAC, H.F., ZANTA, M.A., MERGNY, M.D., SCHERMAN, D., DEMENEIX, B., and BEHR, J.-P. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. U.S.A. 92, 7297-7301.
9. CAPLEN, N.J., ALTON, E.W.F.W., MIDDLETON, P.G., DORIN, J.R., STEVENSON, B., GAO, X., DURHAM, S.R., JEFFERY, P.K., HODSON, M.E., COUTELLE, C., HUANG, L., WILLIAMSON, R., and GEDDES, D.M. (1995a). Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med. 1, 39-46.
10. CAPLEN, N.J., KINRADE, E., SORGI, F., GAO, X., GRUENERT, D., GEDDES, D., COUTELLE, C., HUANG, L., E.W.F.W., A., WILLIAMSON, R. (1995b). In vitro liposome-mediated DNA transfection of epithelial cell lines using the cationic liposome DC-Chol/DOPE. Gene Ther. 2, 603-613.
11. CHENG, F.W., BOAT, T.F., CRANFILL, K., YASKASKAS, J.R., and BOUCHER, R.C. (1989). Increased sulfation of glyconjugates by cultured nasal epithelial cells from patients with cystic fibrosis. J. Clin. Invest. 84, 68-72.
12. COUFFINHAL, T., KEARNEY, M., SULLIVAN, A., SILVER, M., TSURUMI, Y., and ISNER, J.M. (1997). Histochemical staining following LacZ gene transfer underestimates transfection efficiency. Hum. Gene Ther. 8, 929-934.
13. DE BENTZMANN, S., ROGER, P., DUPUIT, F., BAJOLET-LAUDINAT, O., FUCHEY, C., PLOTKOWSKI, M., and PUCHELLE, E. (1996). Asialo GM1 is a receptor for Pseudomonas aeruginosa adherence to regenerating respiratory epithelial cells. Infect. Immun. 64, 1582-1588.
14. FASSENDER, A.J., ZABNER, J., and WELSH, M.J. (1995). Optimization of cationic lipid-mediated gene transfer to airway epithelial. Am. J. Physiol. (Lung Cell. Mol. Physiol.). 13, L45-L51.
15. GAO, X., and HUANG, L. (1995). Cationic liposome-mediated gene transfer. Gene Ther. 2, 710-722.
16. GOLDMAN, M.J., YANG, Y., and WILSON, J.M. (1995). Gene therapy in a xenograft model of cystic fibrosis lung corrects chloride transport more effectively than the sodium defect. Nature Genet. 9, 126-131.
17. GOLDMAN, M.J., ANDERSON, G.M., STOLZENBERG, E.D., KARI, U.P., ZASLOFF, M., and WILSON, J.M. (1997). Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88, 553-560.
18. GRUBB, B., PICKLES, R.J., YE, H., YAKASKAS, J.R., VICK, R.N., ENGELHARDT, J.F., WILSON, J.M., JOHNSON, L.G., and BOUCHER, R.C. (1994). Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature (London) 371, 802-806.
19. JIANG, C., O'CONNOR, S.P., FANG, S.L., WANG, K.X., MARSHALL, J., WILLIAMS, J.L., WILBURN, B., ECHELARD, Y., and CHENG, S.H. (1988). Efficiency of cationic lipid-mediated transfections of polarized and differentiated airway epithelial cells in vitro and in vivo. Hum. Gene Ther. 9, 1531-1542.
20. JOHNSON, L., OLSEN, J., SARKADI, B., MOORE, K., SWANSTROM, R., and BOUCHER, R. (1992). Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nature Genet. 2, 21-25.
21. LUCAKS, G.L., CHANG, X.-B., KARTNER, N., ROTSTEIN, O.D., RIORDAN, J.R., and GRINSTEIN, S. (1992). The cystic fibrosis transmembrane regulator is present and functional in endosomes. J. Biol. Chem. 267, 14568-14572.
22. MATSUI, H., GRUBB, B.R., TARRAN, R., RANDELL, S.H., GATZY, J.T., DAVIS, C.W., and BOUCHER, R.C. (1998). Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95, 1005-1015.
23. MCLACHLAN, G., DAVIDSON, D.J., STEVENSON, B.J., DICKINSON, P., DAVIDSON-SMITH, H., DORIN, J.R., and PORTEOUS, D.J. (1995). Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy. Gene Ther. 2, 614-622.
24. PIER, G.B., GROUT, M., and ZAIDI, T.S. (1997). Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc. Natl. Acad. Sci. U.S.A. 94, 12088-12093.
25. QUINTON, P.M. (1990). Cystic fibrosis: A disease in electrolyte transport. FASEB J. 4, 2709-2717.
26. SAIMAN, L., and PRINCE, A. (1993). Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J. Clin. Invest. 92, 1875-1880.
27. SAIMAN, L., CACALANO, G., GRUENERT, D., and PRINCE, A. (1992). Comparison of adherence of Pseudomonas aeruginosa to respiratory epithelial cells from cystic fibrosis patients and healthy subjects. Infect. Immun. 60, 2808-2814.
28. SMITH, J.J., KARP, P.H., and WELSH, M.J. (1994). Defective fluid transport by cystic fibrosis airway epithelia. J. Clin. Invest. 93, 1307-1311.
29. SMITH, J.J., TRAVIS, S.M., GREENBERG, E.P., and WELSH, M.J. (1996). Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85, 229-236.
30. TRAVIS, S.M., CONWAY, B.A., HILLERTS, N.H., ZABNER, J., SMITH, J.J., SINGH, P., GREENBERG, E.P., and WELSH, M.J. (1998). Analysis of human airway antibacterial factors. Pediatr. Pulmonol. 17(Suppl.), 374.
31. WADSWORTH, S.C. (1998). Cystic fibrosis gene therapy: Four years after the first patient - where are we now? In Highlights, Proceedings of the XIth Annual North American Cystic Fibrosis Conference. (NACFF, Nashville, TN) pp. 8-11.
32. YAMAYA, M., FINKBEINER, W.E., CHUN, S.Y., and WIDDICOMBE, J.H. (1992). Differentiated structure and function of cultures from human tracheal epithelium. Am. J. Physiol. 262, L713-L724.
33. ZABNER, J., COUTURE, L.A., SMITH, A.E., and WELSH, M.J. (1994). Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: Efficiency of adenovirus-mediated gene transfer in vitro. Hum. Gene Ther. 5, 585-593.
34. ZABNER, J., CHENG, S.H., MEEKER, D., LAUNSPACH, J., BALFOUR, R., PERRICONE, M.A., MORRIS, J.E., MARSHALL, J., FASBENDER, A., SMITH, A.E., and WELSH, M.J. (1997). Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo. J. Clin. Invest. 100, 1529-1537.
35. ZAR, H., SAIMAN, L., QUITTELL, L., and PRINCE, A. (1995). Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator. J. Pediatr. 126, 230-233.
36. ZHANG, Y., JIANG, Q., DUDUS, L., YANKASKAS, J.R., and ENGELHARDT, J.F. (1998). Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways. Hum. Gene Ther. 9, 635-648.